Award recordCONTRACT

HELENA LABORATORIES CORPORATION

PIID 36C25020P0631· VHA· 250-NETWORK CONTRACT OFFICE 10 (36C250)· 6550 · IN VITRO DIAGNOSTIC SUBSTANCES, REAGENTS, TEST KITS AND SETS· FY2020· $47,722 net obligations· UEI P31QQPK7RDA5· TX

Description

MODIFICATION TO DE-OBLIGATE EXCESS FY20 FUNDS.

Base award description: ELECTROPHORESIS COST PER TEST SUPPLIES

First action · last action
2020-01-29 · 2021-05-06
Transactions
2
First transaction's obligation
$49,448
Base + all options value (sum of deltas)
$47,722
Extent competed
NOT COMPETED
Other than full & open authority
ONLY ONE SOURCE-OTHER (FAR 6.302-1 OTHER)
Set-aside
NO SET ASIDE USED.
Offers received
1
SDVOSB flag on record
No
NAICS
325413 · IN-VITRO DIAGNOSTIC SUBSTANCE MANUFACTURING

Modification chain · 2 transactions

Each row is one published transaction. This action is the obligation recorded on that transaction — a change amount, as USAspending publishes it. Running total is computed by Glassbox VA as the cumulative sum of those amounts up to and including the row, so the last running total equals the award's net obligations shown above. The cumulative-total columns in the source files are not used: they are not frozen per modification.

$49,448$0Base award · 2020-01-29 · this action $49,448 · running total $49,448Modification P00001 · 2021-05-06 · this action -$1,726 · running total $47,722
  • Base2020-01-29+$49,448= $49,448
  • Mod P000012021-05-06-$1,726= $47,722
TransactionAction dateThis action (delta)Running totalDescription on this transaction
Base2020-01-29+$49,448$49,448ELECTROPHORESIS COST PER TEST SUPPLIES
Mod P00001· CLOSE OUT2021-05-06−$1,726$47,722MODIFICATION TO DE-OBLIGATE EXCESS FY20 FUNDS.

Related awards · 11

Awards are related by an explicit link in the data, stated for each group below — never by text similarity. Values are net obligations.

Other VA awards to the same recipient (UEI P31QQPK7RDA5)

AwardOffice · PSC / listingNet obligationsFY
36C26026N0385260-NETWORK CONTRACT OFFICE 20 (36C260) · 6550 · IN VITRO DIAGNOSTIC SUBSTANCES, REAGENTS, TEST KITS AND SETS$167,781FY2026
36C24426P0411244-NETWORK CONTRACT OFFICE 4 (36C244) · 6550 · IN VITRO DIAGNOSTIC SUBSTANCES, REAGENTS, TEST KITS AND SETS$56,685FY2026
36C25026N0494250-NETWORK CONTRACT OFFICE 10 (36C250) · 6640 · LABORATORY EQUIPMENT AND SUPPLIES$71,078FY2026
36C25926N0302NETWORK CONTRACT OFFICE 19 (36C259) · 6640 · LABORATORY EQUIPMENT AND SUPPLIES$48,920FY2026
36C24426P0173244-NETWORK CONTRACT OFFICE 4 (36C244) · 6550 · IN VITRO DIAGNOSTIC SUBSTANCES, REAGENTS, TEST KITS AND SETS$27,580FY2026
36C26026A0009260-NETWORK CONTRACT OFFICE 20 (36C260) · 6550 · IN VITRO DIAGNOSTIC SUBSTANCES, REAGENTS, TEST KITS AND SETS$0FY2026

Other recipients under 6550 from 250-NETWORK CONTRACT OFFICE 10 (36C250) (most recent first)

AwardRecipientOfficeNet obligationsFY
36C25026N0794ROCHE DIAGNOSTICS CORPORATION250-NETWORK CONTRACT OFFICE 10 (36C250)$200,000FY2026
36C25026N0788ROCHE DIAGNOSTICS CORPORATION250-NETWORK CONTRACT OFFICE 10 (36C250)$135,282FY2026
36C25026N0718ABBOTT LABORATORIES INC.250-NETWORK CONTRACT OFFICE 10 (36C250)$212,150FY2026
36C25026N0778LEICA MICROSYSTEMS INC.250-NETWORK CONTRACT OFFICE 10 (36C250)$120,282FY2026
36C25026F0645GOVERNMENT SCIENTIFIC SOURCE INC250-NETWORK CONTRACT OFFICE 10 (36C250)$53,963FY2026

Cite as: Glassbox VA record view · VA contract (USAspending / FPDS) · CONT_AWD_36C25020P0631_3600_-NONE-_-NONE- · retrieved 2026-09-26.